These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12422914)

  • 1. Screening for antimalarial toxicity: current concepts.
    Easterbrook M
    Can J Ophthalmol; 2002 Oct; 37(6):325-8, 331-4. PubMed ID: 12422914
    [No Abstract]   [Full Text] [Related]  

  • 2. Current concepts in monitoring patients on antimalarials.
    Easterbrook M
    Aust N Z J Ophthalmol; 1998 May; 26(2):101-3. PubMed ID: 9630287
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and prevention of maculopathy associated with antimalarial agents.
    Easterbrook M
    Int Ophthalmol Clin; 1999; 39(2):49-57. PubMed ID: 10343924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review.
    Wiacek MP; Bobrowska-Snarska D; Lubiński W; Brzosko M; Modrzejewska M
    Niger J Clin Pract; 2017 Aug; 20(8):919-923. PubMed ID: 28891533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal toxicity induced by antimalarial drugs: literature review and case report.
    Garza-Leon M; Flores-Alvarado DE; Muñoz-Bravo JM
    Medwave; 2016 Jun; 16(5):e6471. PubMed ID: 27391903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is corneal deposition of antimalarial any indication of retinal toxicity?
    Easterbrook M
    Can J Ophthalmol; 1990 Aug; 25(5):249-51. PubMed ID: 2207871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ophthalmologic prevention of chloroquine and hydroxychloroquine induced retinopathy].
    Bui Quoc E; Ingster-Moati I; Rigolet MH; Chosidow O; Bodaghi B
    Ann Dermatol Venereol; 2005 Apr; 132(4):329-37. PubMed ID: 15886559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy and antimalarial drugs--the British experience.
    Spalton DJ
    Lupus; 1996 Jun; 5 Suppl 1():S70-2. PubMed ID: 8803916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?
    Alarcón GS
    Arthritis Rheum; 2002 Feb; 46(2):561. PubMed ID: 11840465
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloroquine-induced retinal toxicity.
    Whitelaw D; Jessop S
    S Afr Med J; 2005 Feb; 95(2):72. PubMed ID: 15751191
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine-induced retinopathy: a dermatologic perspective.
    Tripp JM; Maibach HI
    Am J Clin Dermatol; 2006; 7(3):171-5. PubMed ID: 16734504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy.
    Nebbioso M; Grenga R; Karavitis P
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):249-58. PubMed ID: 19348599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression.
    Modi YS; Singh RP; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):207-17. PubMed ID: 26985794
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of antimalarial therapy.
    Lozier JR; Friedlaender MH
    Int Ophthalmol Clin; 1989; 29(3):172-8. PubMed ID: 2666332
    [No Abstract]   [Full Text] [Related]  

  • 18. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
    Kahn JB; Haberman ID; Reddy S
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.